Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,769
Closed -$2.14M 115
2024
Q3
$2.14M Sell
6,769
-45
-0.7% -$16K 0.47% 40
2024
Q2
$2.55M Buy
6,814
+1,087
+19% +$367K 0.58% 37
2024
Q1
$1.99M Buy
5,727
+1,460
+34% +$553K 0.47% 40
2023
Q4
$1.95M Sell
4,267
-1,345
-24% -$663K 0.51% 40
2023
Q3
$2.73M Sell
5,612
-224
-4% -$105K 0.79% 36
2023
Q2
$2.61M Sell
5,836
-109
-2% -$54.9K 0.69% 38
2023
Q1
$2.89M Sell
5,945
-157
-3% -$77.6K 0.78% 38
2022
Q4
$3.13M Buy
6,102
+540
+10% +$284K 0.9% 38
2022
Q3
$2.7M Sell
5,562
-444
-7% -$216K 0.8% 41
2022
Q2
$2.81M Buy
+6,006
New +$2.67M 0.88% 37

Other funds holding HUM

Fulcrum Capital's HUM Position: Q4 2024 in Review

Fulcrum Capital sold out of Humana (HUM) in Q4 2024, closing a stake of 6,769 shares — an estimated $2.14M sold.

Fulcrum Capital first reported a position in HUM in Q2 2022 and held it in 10 quarters. The position peaked at $3.13M in Q4 2022. 878 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Fulcrum Capital reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Fulcrum Capital sold 6,769 Humana shares in Q4 2024, an estimated $2.14M.
  • Fulcrum Capital first reported a position in Humana in Q2 2022 and held it in 10 quarters.
  • Fulcrum Capital's Humana position peaked at $3.13M in Q4 2022.
  • 878 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Fulcrum Capital's 13F filing for Q4 2024, filed 13 Jan 2025.